ResearcherDartmouth CollegeNo recent work listed
Karen T. Liby
Matched on ORCID iD 0000-0003-3317-3437; OpenAlex author ID A5019578505. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper
Papers 5
- The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Last author DOI 10.3390/cancers13010096↗
- Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer. First author DOI 10.1002/cpph.48↗
- Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1. Co-author DOI 10.1038/s41598-018-34131-1↗
- Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Last author DOI 10.1016/j.canlet.2017.02.021↗
- The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer. Last author DOI 10.1093/carcin/bgw099↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ana S. Leal · 5 shared papers, 2016–2020 · strength 0.59
- Paper Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer. DOI 10.1002/cpph.48↗
- Paper The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Mode… DOI 10.3390/cancers13010096↗
- Paper Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of… DOI 10.1038/s41598-018-34131-1↗
- Michael B. Sporn · 2 shared papers, 2016–2017 · strength 0.17
- Vânia M. Moreira · 1 shared paper, 2018 · strength 0.11
- Laura E. Kolsi · 1 shared paper, 2018 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.